Primary Site >> Liver Cancer

Gene >> FGL2

Journal: World J Gastroenterol. 2008 Oct 21;14(39):5980-9.
Title: Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma.
Author: Su, Kai|Chen, Fang|Yan, Wei-Ming|Zeng, Qi-Li|Xu, Li|Xi, Dong|Pi, Bin|Luo, Xiao-Ping|Ning, Qin
PMID: 18932275
Journal: Liver Int. 2012 Nov;32(10):1585-95.
Title: Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis.
Author: Liu, Yanling|Xu, Li|Zeng, Qili|Wang, Jingli|Wang, Ming|Xi, Dong|Wang, Xiaojing|Yang, Daofeng|Luo, Xiaoping|Ning, Qin
PMID: 22925132
Journal: Hepatol Int. 2014 Sep 25;8(4):567-75.
Title: Soluble FGL2, a novel effector molecule of activated hepatic stellate cells, regulates T-cell function in cirrhotic patients with hepatocellular carcinoma.
Author: Sun, Ying|Xi, Dong|Ding, Wen|Wang, Faxi|Zhou, Haili|Ning, Qin
PMID: 25298849
Journal: J Gene Med. 2016 Jul;18(7):102-11.
Title: Adenovirus-mediated artificial microRNA against human fibrinogen like protein 2 inhibits hepatocellular carcinoma growth.
Author: Wang, Ming|Liu, Junhui|Xi, Dong|Luo, Xiaoping|Ning, Qin
PMID: 27163335